Study of immune changes in people with type 1 diabetes and other diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes diagnosed recently (within 6 months) or you have at least one diabetes-related auto-antibody
- OR you have another type of diabetes or an autoimmune hormone condition
- OR you do not have diabetes or prediabetes (impaired glucose tolerance)
- You must be scheduled to have pancreatic lymph node removal during an abdominal surgery for another medical reason
- You must be able to sign the informed consent and have social security coverage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune cells in children who were recently diagnosed with type 1 diabetes. It involves one extra blood draw to better understand how the immune system attacks the pancreas. If you join, no new treatments are given—just observation and analysis of your child's immune cells.
This study looks at how your immune system changes over time and how that relates to developing type 1 diabetes. You may be able to join if you can have blood drawn, since the study focuses on blood samples.
This study tests two different medications (Anti-Thymocyte Globulin and Adalimumab or Verapamil) to see if they can slow down the loss of insulin production in people with newly diagnosed type 1 diabetes. Participants will be randomly assigned to receive one of the treatments and will be followed for about a year to see how well their bodies still make insulin.
This study measures how “blood fats” move in the body after fasting and controlled eating, comparing people with type 1 diabetes to those without diabetes. It may help researchers understand diabetes-related differences in lipid (fat) handling and improve future treatments.
This study looks at stored blood samples from adults with type 1 diabetes to understand how a protein called GLUT1 affects the immune system. The goal is to find new ways to control autoimmunity, which could lead to better treatments.
This study looks at how a type of immune cell (MAIT cells) and the gut (microbiota and gut lining) change around the time type 1 diabetes starts in children. It may help researchers understand why type 1 diabetes begins and how the gut and immune system are connected.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.